title: Cullinan Therapeutics: Worthy Of A Small Position
source: SeekingAlpha
date: 2025-10-17
url: https://finnhub.io/api/news?id=0ff6cf42130fc3fc9b40c647542d94b513a53386dd0544efb978c5a6013c93ce
Cullinan Therapeutics trades near cash after a major drop, with pipeline risks but upside from CLN-978 and Zipalertinib trials. Read why CGEM stock is a buy.
